2014
DOI: 10.4253/wjge.v6.i7.272
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer

Abstract: Pancreatic cancer is a highly lethal disease with a genetic susceptibility and familial aggregation found in 3%-16% of patients. Early diagnosis remains the only hope for curative treatment and improvement of prognosis. This can be reached by the implementation of an intensive screening program, actually recommended for individuals at high-risk for pancreatic cancer development. The aim of this strategy is to identify premalignant precursors or asymptomatic pancreatic cancer lesions, curable by surgery. Endosc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(23 citation statements)
references
References 158 publications
(212 reference statements)
0
23
0
Order By: Relevance
“…Familial pancreatic cancer is defined as kindreds with at least two first-degree relatives with pancreatic cancer with an as yet unidentified genetic abnormality. [ 8 9 ] In contrast, hereditary pancreatic cancer implies patients with inherited cancer syndromes with a known germline mutation associated with an increased risk of pancreatic cancer. These gene mutations include syndromes such as Lynch syndrome (MLH1, MLH2, MLH6, PMS2), familial breast and ovarian cancer (BRCA1 and BRCA2), familial adenomatous polyposis (FAP), familial atypical multiple mole melanoma (CDKN2A), Peutz–Jeghers (STK11/LKB1) but also hereditary pancreatitis (HPs) (PRSS1, SPINK1, ATM).…”
Section: Hereditary Pancreatic Ductal Adenocarcinomamentioning
confidence: 99%
“…Familial pancreatic cancer is defined as kindreds with at least two first-degree relatives with pancreatic cancer with an as yet unidentified genetic abnormality. [ 8 9 ] In contrast, hereditary pancreatic cancer implies patients with inherited cancer syndromes with a known germline mutation associated with an increased risk of pancreatic cancer. These gene mutations include syndromes such as Lynch syndrome (MLH1, MLH2, MLH6, PMS2), familial breast and ovarian cancer (BRCA1 and BRCA2), familial adenomatous polyposis (FAP), familial atypical multiple mole melanoma (CDKN2A), Peutz–Jeghers (STK11/LKB1) but also hereditary pancreatitis (HPs) (PRSS1, SPINK1, ATM).…”
Section: Hereditary Pancreatic Ductal Adenocarcinomamentioning
confidence: 99%
“…Screening for PC in the general population is not cost-effective as it accounts for an overall low incidence with 3% new cases each year and a lifetime risk of 1.3% in the United States. [ 63 64 ] It is estimated that 5%-10% of PCs arise as a result of genetic susceptibility and/or familial aggregation. [ 51 65 ] A 2007 consensus conference on inherited diseases of the pancreas proposed that screening for PC be restricted to individuals with a >10-fold increased risk of the disease.…”
Section: Screening Guidelinesmentioning
confidence: 99%
“…The best hope for improvement of survival is prevention or very early detection. 1 Primary prevention methods, such as cessation of smoking, reduction of alcohol intake, and proper exercise and dietary regimens, have been historically difficult to implement. Focused prevention methods, including detection of precursor lesions or early-stage pancreatic cancer (PC), might contribute to the prevention of this deadly disease.…”
Section: Introductionmentioning
confidence: 99%